Follow The Filings

CMPR Cimpress PLC

Consumer Discretionary, filed as CIMPRESS PLC (SHS EURO), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 3.7%
  • $124M

Who owns this now

Largest portfolio weights among holders, up to 3.7% (Ben Tsai, Spruce House Investment Management). Not free-float ownership.

  1. Ben Tsai 3.7%

Who owns CMPR

Sorted by value, long equity only, as of 2026 Q2.

History
Ben Tsai, Spruce House Investment Management 3.7% Hold 1,222,633 $124M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CMPR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CMPR insider trades
  • $251K bought by 1 insider
  • $9.3M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Robert S Keane CEO
    Sale
    $2.4M 28,000 shares at $84.89
    Traded Sep 11 Filed Sep 15
    ↗
  2. Robert S Keane CEO
    Sale
    $625K 6,500 shares at $96.09 7.9% of stake
    Traded Aug 11 Filed Aug 13
    ↗
  3. Sean Edward Quinn CFO
    Sale
    $2.9M 27,989 shares at $104.54 49% of stake
    Traded May 27–28 Filed May 29
    ↗
  4. Maarten Wensveen EVP & Chief Technology Officer
    Sale
    $1.8M 19,251 shares at $92.96 50% of stake
    Traded May 5 Filed May 7
    ↗
  5. Sean Edward Quinn CFO
    Buy
    $251K 4,000 shares at $62.79 +12% to stake
    Traded Nov 6, 2025 Filed Nov 7, 2025
    ↗
  6. Maarten Wensveen EVP & Chief Technology Officer
    Sale
    $1.6M 22,830 shares at $68.36 53% of stake
    Traded Nov 3, 2025 Filed Nov 5, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 74 option exercises and 24 share withholdings for taxes.

Congress

No member of Congress reported trading CMPR in the last three years. 1 member listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
10-K Filing Doc
8-K 2.02 Filing Doc
8-K 8.01 Filing Doc
8-K 1.01,2.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13D/A — Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $3.08B $3.29B $3.4B $3.74B
Gross profit * $1.44B $1.6B $1.62B $1.73B
Gross margin * 46.7% 48.5% 47.5% 46.3%
Net income -$185.98M $173.68M $14.95M $95.87M
Net margin * -6.0% 5.3% 0.4% 2.6%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $441.03M $457.98M $502.61M $564.45M
Total non-current assets * $1.41B $1.43B $1.47B $1.64B
Total assets $1.85B $1.89B $1.97B $2.2B
Total current liabilities $645.33M $663.96M $758.66M $775.59M
Total non-current liabilities * $1.82B $1.75B $1.77B $1.83B
Total equity -$623.14M -$550.15M -$583.49M -$493.98M

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $130.29M $350.72M $298.07M $283.71M
Cash from investing -$103.72M -$54.61M -$140.76M -$195.56M
Cash from financing -$177.11M -$222.55M -$135.92M -$68.02M
Net change in cash -$146.74M $73.46M $30.21M $14.87M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.